214 related articles for article (PubMed ID: 20855948)
1. The role of microenvironment in testicular germ cell tumors.
Díez-Torre A; Silván U; Díaz-Núñez M; Aréchaga J
Cancer Biol Ther; 2010 Sep; 10(6):529-36. PubMed ID: 20855948
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of the mitosis-meiosis switch in testicular carcinoma in situ.
Jørgensen A; Nielsen JE; Almstrup K; Toft BG; Petersen BL; Rajpert-De Meyts E
J Pathol; 2013 Mar; 229(4):588-98. PubMed ID: 23303528
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D metabolism and effects on pluripotency genes and cell differentiation in testicular germ cell tumors in vitro and in vivo.
Blomberg Jensen M; Jørgensen A; Nielsen JE; Steinmeyer A; Leffers H; Juul A; Rajpert-De Meyts E
Neoplasia; 2012 Oct; 14(10):952-63. PubMed ID: 23097629
[TBL] [Abstract][Full Text] [Related]
4. [Carcinoma in situ of the testis: predisposition, evolution and early detection].
Biermann K
Pathologe; 2011 Nov; 32 Suppl 2():232-6. PubMed ID: 21850455
[TBL] [Abstract][Full Text] [Related]
5. CDH1 (E-cadherin) in testicular germ cell neoplasia: suppressed translation of mRNA in pre-invasive carcinoma in situ but increased protein levels in advanced tumours.
Sonne SB; Hoei-Hansen CE; Nielsen JE; Herlihy AS; Andersson AM; Almstrup K; Daugaard G; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
APMIS; 2006; 114(7-8):549-58. PubMed ID: 16907861
[TBL] [Abstract][Full Text] [Related]
6. Expression of FGFR3 during human testis development and in germ cell-derived tumours of young adults.
Ewen KA; Olesen IA; Winge SB; Nielsen AR; Nielsen JE; Graem N; Juul A; Rajpert-De Meyts E
Int J Dev Biol; 2013; 57(2-4):141-51. PubMed ID: 23784824
[TBL] [Abstract][Full Text] [Related]
7. PCPH expression is an early event in the development of testicular germ cell tumors.
Regadera J; Blánquez MJ; González-Peramato P; Nistal M; Miller JC; Tirado OM; Notario V
Int J Oncol; 2006 Mar; 28(3):595-604. PubMed ID: 16465363
[TBL] [Abstract][Full Text] [Related]
8. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ.
Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL
BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509
[TBL] [Abstract][Full Text] [Related]
9. Molecular biology of testicular germ cell tumors: unique features awaiting clinical application.
Boublikova L; Buchler T; Stary J; Abrahamova J; Trka J
Crit Rev Oncol Hematol; 2014 Mar; 89(3):366-85. PubMed ID: 24182421
[TBL] [Abstract][Full Text] [Related]
10. [Expression levels of the IAP antagonists XAF1, Smac/DIABLO and HtrA2 in testicular germ cell tumours].
Kempkensteffen C; Hinz S; Jäger T; Weikert S; Krause H; Schostak M; Christoph F; Strenziok R; Miller K; Schrader M
Aktuelle Urol; 2008 Nov; 39(6):436-41. PubMed ID: 18979398
[TBL] [Abstract][Full Text] [Related]
11. [Molecular Pathogenesis of Testicular Germ Cell Tumors].
Bakardjieva-Mihaylova V; Škvárová Kramarzová K; Slámová M; Büchler T; Boublíková L
Klin Onkol; 2017; 30(6):412-419. PubMed ID: 29271211
[TBL] [Abstract][Full Text] [Related]
12. High-resolution telomere fluorescence in situ hybridization reveals intriguing anomalies in germ cell tumors.
Shekhani MT; Barber JR; Bezerra SM; Heaphy CM; Gonzalez Roibon ND; Taheri D; Reis LO; Guner G; Joshu CE; Netto GJ; Meeker AK
Hum Pathol; 2016 Aug; 54():106-12. PubMed ID: 27085557
[TBL] [Abstract][Full Text] [Related]
13. From embryonic stem cells to testicular germ cell cancer-- should we be concerned?
Almstrup K; Sonne SB; Hoei-Hansen CE; Ottesen AM; Nielsen JE; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Int J Androl; 2006 Feb; 29(1):211-8. PubMed ID: 16466542
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma in situ in the testis.
Rørth M; Rajpert-De Meyts E; Andersson L; Dieckmann KP; Fosså SD; Grigor KM; Hendry WF; Herr HW; Looijenga LH; Oosterhuis JW; Skakkebaek NE
Scand J Urol Nephrol Suppl; 2000; (205):166-86. PubMed ID: 11144894
[TBL] [Abstract][Full Text] [Related]
15. Cancer Stem Cell Niche and Immune-Active Tumor Microenvironment in Testicular Germ Cell Tumors.
Kalavska K; Kucerova L; Schmidtova S; Chovanec M; Mego M
Adv Exp Med Biol; 2020; 1226():111-121. PubMed ID: 32030680
[TBL] [Abstract][Full Text] [Related]
16. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2.
Cardenas RP; Zyoud A; McIntyre A; Alberio R; Mongan NP; Allegrucci C
Stem Cell Res Ther; 2024 May; 15(1):128. PubMed ID: 38693576
[TBL] [Abstract][Full Text] [Related]
17. Involvement of epigenetic modifiers in the pathogenesis of testicular dysgenesis and germ cell cancer.
Lawaetz AC; Almstrup K
Biomol Concepts; 2015 Jun; 6(3):219-27. PubMed ID: 26103631
[TBL] [Abstract][Full Text] [Related]
18. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.
Rajpert-De Meyts E
Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528
[TBL] [Abstract][Full Text] [Related]
19. ITGCN of the testis, contralateral testicular biopsy and bilateral testicular cancer.
Karellas ME; Damjanov I; Holzbeierlein JM
Urol Clin North Am; 2007 May; 34(2):119-25; abstract vii. PubMed ID: 17484917
[TBL] [Abstract][Full Text] [Related]
20. A miR-125b/CSF1-CX3CL1/tumor-associated macrophage recruitment axis controls testicular germ cell tumor growth.
Batool A; Wang YQ; Hao XX; Chen SR; Liu YX
Cell Death Dis; 2018 Sep; 9(10):962. PubMed ID: 30237497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
